Assessing Durvalumab and FLOT Chemotherapy in Resectable Gastric and Gastroesophageal Junction Cancer
Running, not enrolling · Phase 3 · Has a placebo group
Conditions studied: Gastrointestinal Neoplasms, Esophagogastric Junction
In brief
This is a Global Study of Neoadjuvant-Adjuvant Durvalumab or Placebo and FLOT Chemotherapy Followed by Adjuvant Durvalumab or Placebo in Patients with Resectable Gastric and Gastroesophageal Cancer (GC/GEJC) (MATTERHORN).
Key facts
- Study ID
- NCT04592913
- Run by
- AstraZeneca
- People needed
- 957
- Starts
- 2020-11-17
- Expected to finish
- 2027-09-27
- Last updated by the study team
- 2025-12-24
Who can join
Age: 18 and older, up to 200. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Research Site — Los Angeles, California, United States
- Research Site — Los Angeles, California, United States
- Research Site — Sylmar, California, United States
- Research Site — St. Petersburg, Florida, United States
- Research Site — Tallahassee, Florida, United States
- Research Site — West Palm Beach, Florida, United States
- Research Site — Fort Wayne, Indiana, United States
- Research Site — Louisville, Kentucky, United States
- Research Site — Boston, Massachusetts, United States
- Research Site — New York, New York, United States
- Research Site — Rochester, New York, United States
- Research Site — Nashville, Tennessee, United States
- Research Site — Dallas, Texas, United States
- Research Site — Lancaster, Texas, United States
- Research Site — Seattle, Washington, United States
- Research Site — Buenos Aires, Argentina
- Research Site — Ciudad Autonoma Buenos Aires, Argentina
- Research Site — Ciudad de Buenos Aires, Argentina
- Research Site — Ciudad de Buenos Aires, Argentina
- Research Site — Rosario, Argentina
- Research Site — Rosario, Argentina
- Research Site — Charleroi, Belgium
- Research Site — Edegem, Belgium
- Research Site — Leuven, Belgium
- Research Site — Duarte, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.